Accessibility Menu

AstraZeneca Plc(FRA) ZEG

Market Cap€213.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+818%
5 Year+102%
1 Year+11%
1 Month+0%
€135.80
+0.85%
+1.15Today
AstraZeneca Plc last closing stock price
MetricPriceDate
Last closeEUR 160.702026-03-05
AstraZeneca Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%EUR 160.702026-02-26
1 month+0.19%EUR 160.402026-02-03
3 month+3.18%EUR 155.752025-12-05
Year to date+1.81%EUR 157.852025-12-30
1 year+11.17%EUR 144.552025-03-05
3 year+32.65%EUR 121.152023-03-06
5 year+102.39%EUR 79.402021-03-05
Since inception+818.44%EUR 14.662008-04-07

AstraZeneca Plc Financials at a Glance

Market Cap

€213.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€52.62K

Net Income (TTM)

€8.96K

EPS (TTM)

€5.74

P/E Ratio

23.84

Dividend

€2.75

Beta (Volatility)

-0.03 (Low)

Price

€135.80

Volume

451

Open

€135.00

Previous Close

€134.65

Daily Range

€135.00 - €136.30

52-Week Range

€125.00 - €180.45

Estimated Earnings Date

N/A

ZEG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AstraZeneca Plc

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Industry

Pharmaceuticals

Employees

96,100

CEO

Pascal Soriot, MBA, DVM

ZEG Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

21.82%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.19%

Dividend Yield

2.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€213.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.55B

Volume

451

Avg. Volume

941.985

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

AstraZeneca Plc Performance Analysis

AstraZeneca Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 42,199,889,47331.8%
20232023-12-31EUR 42,373,821,8870.4%
20242024-12-31EUR 49,989,333,53618.0%
20252025-12-31EUR 52,046,914,4114.1%
AstraZeneca Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 2.012920.3%
20232023-12-31EUR 3.5375.8%
20242024-12-31EUR 4.1618.0%
20252025-12-31EUR 5.8039.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€13.23K

+1.0%

Gross Profit

€9.73K

+1.0%

Gross Margin

73.55%

+1.0%

Market Cap

€213.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€2.64

N/A

Employees

96,100

N/A

Net Income

€2.16K

+1.0%

EBITDA

€4.34K

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€32.48K

-4.4%

Total Debt

€28.20K

+1.0%

Accounts Receivable

€12.53K

+1.0%

Inventory

€6.06K

+1.1%

Long Term Debt

€22.75K

+1.0%

Short Term Debt

€5.45K

+0.9%

Return on Assets

9.09%

+1.1%

Return on Invested Capital

7.90%

+1.1%

Free Cash Flow

€1.86K

+0.8%

Operating Cash Flow

€2.52K

+0.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,785.76-0.00%
^DJIDJI
$53,732.41-0.00%
^IXICNASDAQ
$26,729.16-0.00%
BTCBitcoin
$63,110.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$144.95-0.00%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$40.28+0.00%
SPCXSpace Exploration Technologies
$140.00-0.01%
NOKNokia
$10.76+0.02%

Questions About ZEG

What is the current price of AstraZeneca Plc?

AstraZeneca Plc is trading at €135.80 per share.

What is the 52-week range for AstraZeneca Plc?

Over the past 52 weeks, AstraZeneca Plc has traded between €125.00 and €180.45.

How much debt does AstraZeneca Plc have?

As of the most recent reporting period, AstraZeneca Plc reported total debt of €28.20B.

How much cash does AstraZeneca Plc have on hand?

AstraZeneca Plc reported €4.28B in cash and cash equivalents in its most recent financial results.

What is AstraZeneca Plc’s dividend yield?

AstraZeneca Plc currently has a dividend yield of 2.00%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.